Abstract
The methodology of psychopharmacological studies is getting more and more complex. Simultaneously sponsor- and publication bias limit their interpretation. Therefore, this article tries to explain a number of aspects concerning study designs, randomisation, blinding, case numbers, in- and exclusion criteria, psychiatric rating scales, comparator compounds and doses, statistical methods and numbers, publication bias and presentation of results. The aim is to make the reading and interpretation of clinical trials in schizophrenia easier.
| Translated title of the contribution | Methodology and critical interpretation of psychopharmacological studies in schizophrenia |
|---|---|
| Original language | German |
| Pages (from-to) | 231-240 |
| Number of pages | 10 |
| Journal | Psychopharmakotherapie |
| Volume | 13 |
| Issue number | 6 |
| State | Published - Nov 2006 |
| Externally published | Yes |
